The mTOR pathway in the antiphospholipid syndrome
This perspective discussed the available evidence on the involvement of mTOR pathway in antiphospholipid syndrome (APS), from the aspects of endothelial cells, platelets, monocytes and anti-phospholipid antibodies (PLs), which may lead to future therapeutic applications of mTOR inhibition in APS.
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
De Gruyter
2023-12-01
|
| Colección: | Medical Review |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1515/mr-2023-0033 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|